If your GP has referred you for a prostate MRI, or your urologist has recommended one after an elevated PSA, you are probably wondering what the scan actually shows — and more importantly, what it means if something is found.

This article explains what a prostate MRI involves, how results are reported, and how the findings guide the next steps. The goal is to make the process less opaque before you go in.

Noticing blood in your urine is frightening. It is the kind of symptom that stops people mid-thought and sends them straight to their phone to search for answers, usually late at night when they are already worried.

This article explains what blood in the urine actually means, when it needs urgent attention, and what a proper assessment involves. The goal is to replace anxiety with information — so that whatever is causing it, you know what to do next.

The urological cancers most likely to present through general practice — prostate, kidney and bladder — are often detectable at a stage where treatment options are meaningful. The referrals that matter most are the ones where a GP recognises a red flag early and moves on it.

This guide focuses on the cancer-relevant triggers that warrant urological assessment, what to include, and when to move urgently.

Age changes the context of cancer care. This article explains how surveillance and treatment decisions evolve as risk, health and priorities shift over time.

Living with cancer on active surveillance can feel harder than expected. This article explores the practical and emotional realities, and how patients are supported over time.

Robotic surgery is a tool in kidney cancer care — not the treatment itself. This article explains when robotic surgery helps, when it doesn’t, and how decisions are really made.

An honest overview of life after radical cystectomy, including recovery, urinary diversion, emotional adjustment and how patients and families adapt over time.

Active surveillance can be the right choice for selected urologic cancers. Learn when monitoring is appropriate, how risk is assessed, and what follow-up involves.

Recovery after robotic cancer surgery is rarely linear. This article explains what patients often underestimate about fatigue, function and emotional adjustment.

An overview of modern bladder cancer surgery, from transurethral procedures to cystectomy, explaining when each approach is used and why decisions are staged.

Positive margins and rising PSA after prostate cancer surgery are common and often misunderstood. This article explains what they mean and how salvage treatment decisions are made.

One of the most important decisions made in kidney cancer surgery is not whether to operate, but how much kidney to remove.

Patients are often told they need “kidney surgery” and understandably assume the choice is straightforward: remove the tumour, remove the kidney, move on. In reality, the decision between partial nephrectomy (removing the tumour while preserving the rest of the kidney) and radical nephrectomy (removing the entire kidney) is one of the most nuanced judgement calls in urologic oncology.

Not all kidney cancers require immediate surgery. This article explains when surgery is recommended, when surveillance is appropriate, and how decisions are individualised.

How surgeons decide between partial and radical nephrectomy in kidney cancer, balancing oncological safety with long-term kidney health.

Surgery and radiation are both valid treatments for prostate cancer. Learn how decisions are made, what factors influence recommendations, and how care is individualised.